Cat. No. | Product name | CAS No. |
DC22916 |
JNJ-10397049
A potent, selective, and bioavailable OX2 receptor antagonist with Kb of 4.5 nM. |
708275-58-5 |
DC23971 |
LY450108
A potent, selective, and centrally active positive allosteric modulator of AMPAR-mediated neurotransmission, which increase ion channel flux in the presence of agonist by suppressing desensitization and/or deactivation of the receptors.. |
376594-67-1 |
DC24030 |
LY451395
A potent, selective, and centrally active positive allosteric modulator of AMPAR-mediated neurotransmission, which increase ion channel flux in the presence of agonist by suppressing desensitization and/or deactivation of the receptors.. |
375345-95-2 |
DC23963 |
QL-47
A potent, selective, and irreversible BTK inhibitor with IC50 of 7 nM. |
1469988-75-7 |
DC21545 |
PXS-4681A
A potent, selective, and irreversible inhibitor of SSAO/VAP-1 (AOC3) with Ki of 37 nM, IC50 of <10 nM. |
1478364-87-2 |
DC11850 |
MK-7145
A potent, selective, and oral renal outer medullary potassium channel (ROMK) inhibitor with IC50 of 68 nM. |
1255204-84-2 |
DC11727 |
RO-2468
A potent, selective, and orally active p53-MDM2 antagonist with IC50 of 6 nM. |
1360821-21-1 |
DC11728 |
RO-5353
A potent, selective, and orally active p53-MDM2 antagonist with IC50 of 7 nM. |
1360821-61-9 |
DC21254 |
LY-517717
A potent, selective, and orally bioavailable factor Xa (FXa) inhibitor for prevention and treatment of thromboembolic diseases.. |
313489-71-3 |
DC21487 |
PF-05190457
Featured
A potent, selective, and orally bioavailable ghrelin receptor (GHSR) inverse agonist with binding pKi of 8.36. |
1334782-79-4 |
DC23541 |
IRAK4-IN-16
A potent, selective, and orally bioavailable inhibitor of interleukin-1 receptor-associate kinase-4 (IRAK4) with IC50 of 2.8 nM, 217- and 892-fold selectivity over IRAK-1 and TAK1, respectively. |
509093-72-5 |
DC23949 |
CX-6258 hydrochloride hydrate
A potent, selective, and orally efficacious pan-Pim inhibitor with IC50 of 5/25/16 nM for Pim1/2/3, respectively. |
1353858-99-7 |
DC23036 |
BI-69A11
A potent, selective, ATP competitive AKT inhibitor with IC50 of 2.3 uM for Akt1. |
1233322-09-2 |
DC22651 |
PF-4950834
A potent, selective, ATP-competitive and orally acitve Rho kinase inhibitor with IC50 of 33.1 and 8.5 nM for ROCK1 and ROCK2, respectively. |
1256264-62-6 |
DC23867 |
PF-00337210
A potent, selective, ATP-competitive and orally bioavailable inhibitor of VEGFR-2 with Ki of 0.7 and 8.8 nM for unactivated and fully phosphorylated VEGFR-2, respectively. |
854514-88-8 |
DC11711 |
VER-158411
A potent, selective, ATP-competitive Chk1 and Chk2 inhibitor with IC50 of 4.4 nM and 4.5 nM, respectively. |
1174664-88-0 |
DC11733 |
SAR-020106
A potent, selective, ATP-competitive Chk1 inhibitor with IC50 of 13.3 nM. |
184843-57-9 |
DC12007 |
SOMG-833
A potent, selective, ATP-competitive c-MET inhibitor with IC50 of 0.93 nM. |
1268264-10-3 |
DC23930 |
Bay 65-1942
A potent, selective, ATP-competitive inhibitor of IKKβ kinase with Ki of 2 nM. |
600734-02-9 |
DC22500 |
Bay 65-1942 hydrochloride
A potent, selective, ATP-competitive inhibitor of IKKβ kinase with Ki of 2 nM. |
600734-06-3 |
DC23070 |
MAP4K4-IN-11e
A potent, selective, ATP-competitive inhibitor of MAP4K4 with IC50 of 1.9 uM, without effect on other stress pathway related kinases. |
1774346-60-9 |
DC23964 |
BMS-509744
A potent, selective, ATP-competitive ITK inhibitor with IC50 of 19 nM. |
439575-02-7 |